Schweitzer Fachinformationen
Wenn es um professionelles Wissen geht, ist Schweitzer Fachinformationen wegweisend. Kunden aus Recht und Beratung sowie Unternehmen, öffentliche Verwaltungen und Bibliotheken erhalten komplette Lösungen zum Beschaffen, Verwalten und Nutzen von digitalen und gedruckten Medien.
Comprehensive coverage of major families of viruses, including human pathogens and viruses of organisms from bacteria to plants, with updated information on antiviral drugs, vaccines, antiviral immunity, and gene therapy
Fundamentals of Molecular Virology is a textbook designed for university students learning about viruses at the undergraduate or graduate levels. Chapters contributed by prominent virologists cover many of the major virus families. Each chapter is designed to tell a story about the viruses covered, including information on discovery, diseases and pathogenesis, virus structure, steps in replication, and interaction with cellular signaling pathways. This approach portrays the "personality" of each virus, helping students to learn the material and build up their knowledge of virology starting with smaller and simpler viruses and proceeding to more complex viruses.
Major importance is given to viruses that infect humans and cause disease, but coverage is broad, including viruses of bacteria, Archaea, algae, invertebrates, and plants. Information boxes highlight applications and research directions of particular significance. Chapters conclude with sections presenting fundamental concepts, review questions, and lists of key terms, which are defined in a glossary at the end of the book.
This 3rd edition of Fundamentals of Molecular Virology includes detailed information on the recent COVID-19 pandemic and mRNA vaccine technology, additional sections on pathogenic herpesviruses, and updates on recent outbreaks of Zika virus, Ebola virus and mpox diseases. New chapters describe hepatitis C virus, rhabdoviruses, viruses of invertebrates, oncolytic viruses, and virus-mediated gene therapy. All chapters, including those on innate and adaptive immune responses to virus infections, virus vaccines, and antiviral agents, were revised and updated.
Christopher D. Richardson is Professor, Department of Microbiology & Immunology, Department of Pediatrics, Dalhousie University, Canada. Dr. Chris Richardson is a molecular virologist with 35 years of experience working with a variety of viruses. He earned his PhD at the University of British Columbia and did postdoctoral work at The Rockefeller University and the National Institutes of Health (Bethesda, USA). He previously held faculty positions at the National Research Council of Canada, McGill University, and the University of Toronto.
Nicholas H. Acheson is Emeritus Professor of Microbiology & Immunology at McGill University, Quebec, Canada. He earned his PhD from The Rockefeller University and was a postdoctoral fellow at the Swiss Institute for Experimental Cancer Research (Lausanne) and Institut Pasteur (Paris). He carried out research on Semliki Forest virus and mouse polyomavirus, and taught a virology course for advanced undergraduate students at McGill University.
Section I: Introduction To Virology
1. Introduction to Virology 2Nicholas H. Acheson, McGill University Christopher D. Richardson, Dalhousie University
2. Virus Structure and Assembly 19Stephen C. Harrison, Harvard University
3. Virus Classification: The World of Viruses 32Nicholas H. Acheson, McGill University Christopher D. Richardson, Dalhousie University
4. Virus Entry 47Ari Helenius, Swiss Federal Institute of Technology, Zurich
Section II: Viruses of Bacteria And Archaea
5. Single-Stranded RNA Bacteriophages 60Jan van Duin, University of Leiden Karthik Chamakura, Armata Pharmaceuticals, Inc., Los Angeles Ryland Young, Texas A&M University
6. Microviruses 74Bentley A. Fane, University of Arizona Aaron P. Roznowski, University of Arizona
7. Bacteriophage T7 84William C. Summers, Yale University Ian J. Molineux, University of Texas, Austin
8. Bacteriophage T4 94Deborah M. Hinton, National Institutes of Health, Bethesda Eric S. Miller, North Carolina State University
9. Bacteriophage Lambda 110Michael Feiss, University of Iowa
10. Viruses of Archaea 123David Prangishvili, Institut Pasteur, Paris Mart Krupovic, Institut Pasteur, Paris
Section III: Positive-Strand Rna Animal Viruses
11. Picornaviruses 140Bert L. Semler, University of California, Irvine
12. Flaviviruses 152Richard Kuhn, Purdue University Shelton Bradrick, Trudeau Institute, New York
13. Hepaciviruses 164John Lok Man Law, Memorial University of Newfoundland Michael Houghton, University of Alberta
14. Togaviruses and Rubella Virus 178Anil Kumar, University of Saskatchewan Milton Schlesinger, Washington University, St. Louis Sondra Schlesinger, Washington University, St. Louis Tom C. Hobman, University of Alberta
15. Coronaviruses 192Marc Desforges, Ste. Justine Hospital, Université de Montréal Pierre Talbot, Institut Armand-Frappier Mark Denison, Vanderbilt University
Section IV: Negative-Strand and Double-Stranded Rna Animal Viruses
16. Paramyxoviruses and Pneumoviruses 210Copyrighted Material Nicholas H. Acheson, McGill University Daniel Kolakofsky, University of Geneva Laurent Roux, University of Geneva Christopher D. Richardson, Dalhousie University
17. Rhabdoviruses 226Valery Grdzelishvili, University of North Carolina, Charlotte Cassandra A. Catacalos, University of North Carolina, Charlotte
18. Filoviruses 237Heinz Feldmann, Rocky Mountain Laboratories, Montana Hans-Dieter Klenk, University of Marburg Nicholas H. Acheson, McGill University Angela Rasmussen, University of Saskatchewan
19. Bunyaviruses 251Richard M. Elliott, University of Glasgow Lev Levanov, University of Helsinki Alexander Plyusnin, University of Helsinki
20. Influenza Viruses 262Dalius J. Briedis, McGill University Alyson Kelvin, University of Calgary
21. Reoviruses 278Kristen M. Ogden, Vanderbilt University Terence S. Dermody, University of Pittsburgh School of Medicine
Section V: Small Dna Animal Viruses
22. Parvoviruses 292Peter Beard, École Polytechnique Fédérale de Lausanne Sarah Wootton, University of Guelph
23. Polyomaviruses 302Nicholas H. Acheson, McGill University James A. DeCaprio, Dana-Farber Cancer Institute, Harvard University
24. Papillomaviruses 318Greg Matlashewski, McGill University Lawrence Banks, International Centre for Genetic Engineering and Biotechnology, Trieste Miranda Thomas, International Centre for Genetic Engineering and Biotechnology, Trieste
Section VI: Large Dna Animal Viruses
25. Adenoviruses 330Philip Branton, McGill University Richard C. Marcellus, McGill University Luca D. Bertzbach, Leibniz Institute of Virology, Hamburg Thomas Dobner, Leibniz Institute of Virology, Hamburg
26. Herpesviruses 344Bernard Roizman, University of Chicago Gabriella Campadelli-Fiume, University of Bologna Richard Longnecker, Northwestern University Bruce Banfield, Queens University Craig McCormick, Dalhousie University
27. Poxviruses 366Richard Condit, University of Florida Matthew D. Gresseth, Medical University of South Carolina Paula Traktman, Medical University of South Carolina
Section VII: Viruses with a Reverse Transcriptase
28. Retroviruses 382Alan Cochrane, University of Toronto
29. Human Immunodeficiency Virus 394Alan Cochrane, University of Toronto
30. Hepadnaviruses 406Christopher D. Richardson, Dalhousie University William Addison, University of Alberta D. Lorne Tyrrell, University of Alberta
Section VIII: Viroids and Prions
31. Viroids and Hepatitis Delta Virus 420Jean-Pierre Perreault, Université de Sherbrooke Martin Pelchat, University of Ottawa Charith Raj Adkar-Purushothama, Université de Sherbrooke
32. Prions 431Dalius J. Briedis, McGill University David Westaway, University of California, San Francisco
Section IX: Viruses of Plants, Algae, And Invertebrates
33. Cucumber Mosaic Virus 444Marilyn J. Roossinck, Pennsylvania State College of Agricultural Sciences
34. Viruses of Algae and Mimivirus, a Giant Virus 457Michael J. Allen, University of Exeter William H. Wilson, Marine Biological Association, Plymouth John A. Duffy, University of Exeter
35. Baculoviruses 478Eric Carstens, Queens University Robert L. Harrison, U.S. Department of Agriculture, Beltsville, Maryland
36. Viruses of Invertebrates 489Peter Krell, University of Guelph
Section X: Host Defenses Against Virus Infection
37. Innate Immune Responses Against Virus Infection 506Karen Mossman, McMaster University John Hiscott, Istituto Pasteur-Fondazione Cenci Bolognetti, Rome Alessandra Zevini, Istituto Pasteur-Fondazione Cenci Bolognetti, Rome
38. Adaptive Immune Responses to Virus Infection 527Malcolm G. Baines, McGill University Karen Mossman, McMaster University Naglaa Shoukry, University of Montreal
Section XI: Medical Applications of Virology
39. Antiviral Vaccines 542Brian Ward, McGill University Hilary E. Hendin, McGill University
40. Antiviral Chemotherapy 562Donald M. Coen, Harvard Medical School
41. Oncolytic Viruses 578Vishnupriyan Kumar, Dalhousie University Liang-Tzung Lin, Taipei Medical University Shashi Gujar, Dalhousie University
42. Virus-Mediated Gene Therapy 586Richard Peluso, Renovacor, Philadelphia Christopher D. Richardson, Dalhousie University
This book is written for students who are learning about viruses for the first time in a university course at the undergraduate or graduate level. As the title implies, it concentrates on the molecular mechanisms of virus replication and on the interactions between viruses and the cells in which they replicate. The book approaches learning about virology by presenting chapters, many of which cover a specific virus family, using one or two well-studied viruses as examples. Several other chapters discuss a variety of the many viruses that infect Archaea, algae, or invertebrates. These chapters are each designed to tell a story about the viruses being considered and to portray their "personality", with the idea that this will help students learn about and remember each virus group.
This organizational scheme has been used in a number of successful virology textbooks, including Salvador Luria's classic 1953 book, General Virology. Luria was one of the founding members of the "phage group," a coalition of physicists, biologists, and chemists who, during the 1940s, chose to study bacteriophages in order to understand the molecular basis of life and, in doing so, invented the field of molecular biology. Their approach was to study how the proteins and nucleic acids of viruses interact with cellular molecules and organelles, transforming the cell into a factory that can produce many new progeny virus particles. Their underlying hope, which was largely achieved, was to use viruses as a tool to help understand how cells work.
The amount of knowledge that has accumulated about viruses has expanded enormously in recent years, as in many other areas of biomedical sciences. Fields Virology has become the classic reference book for knowledge about human and animal viruses during the past 40 years; that book is also organized in chapters that cover specific virus families. Our own teaching experience and conversations with numerous colleagues have convinced us that there is a real need for a concise, up-to-date textbook organized around the concept of virus families and designed specifically for teaching university students.
The problem was to make such a book accessible to beginning students without oversimplifying the material. Our approach was to ask a number of prominent virology researchers and teachers to write chapters on viruses that they knew well, using a set of criteria that we provided. We then edited and sometimes rewrote these chapters into a common style, and, in many cases, we created or redesigned the illustrations.
No individual could possibly write knowledgeably about the large spectrum of viruses that a virology course should cover, so a collaborative approach was necessary. However, a textbook that is an effective learning tool must have a coherent organization and a clear, consistent style of writing and illustration. Our job has been to craft the original chapters that we received into what we hope are readable and easily understood units.
This textbook emphasizes virus replication strategies; it is directed toward university students studying microbiology, cell and molecular biology, and the biomedical sciences. It does not go deeply into pathogenesis, epidemiology, or disease symptoms. However, substantial information and stories about medical and historical aspects of virology are included, particularly in the introductory sections of each chapter. Students who understand the diseases caused by particular viruses, and their importance in human history, may be motivated to learn more about those viruses.
The second edition of this book, published in 2011, expanded coverage to include additional viruses and chapters on innate and adaptive immune responses to virus infection. New full-color figures were introduced. It was well-received and was adopted as a text for many university-based virology courses in North America and overseas. Work on the current third edition began shortly before the COVID-19 pandemic, when Christopher Richardson accepted the job of planning and coordinating this revision. Chris began to recruit virology researchers and educators to update and revise existing chapters, as well as soliciting several additional chapters. The COVID-19 pandemic inevitably slowed down work on this revision but also gave us the chance to include detailed descriptions of the pandemic and its life-changing effects on the entire planet, in the chapter on coronaviruses.
All chapters in this book were reviewed and updated, some in depth. However, the organization and content of each chapter were retained in most cases. We have therefore cited on the title page of each chapter the names of the original contributors as well as those of the individuals who revised or rewrote the chapter.
This third edition includes five new chapters: (1) "Bacteriophage T4," one of the best-studied and most complex phages; (2) "Hepatitis C Virus," the story about a relatively recent viral disease for which efficient antiviral agents that cure infected individuals have been developed; (3) "Viruses of Invertebrates," a growing field with many diverse viruses, which has developed through the efforts of high-throughput sequencing, resulting in the discovery of thousands of viral genomes derived from environmental samples; (4) "Oncolytic Viral Agents," a field that is starting to show some promise for treatment of certain human cancers; and (5) "Virus-Mediated Gene Therapy," a field under development for decades that has now progressed from its infancy to adolescence. This last chapter discusses how viral vectors have been harnessed to yield clinical successes in treating inherited human diseases and some cancers. The field has embraced CRISPR/Cas gene editing, which evolved from studying defense mechanisms in phage infections of bacteria. The merging of these technologies shows promise in treating debilitating diseases such as sickle cell disease, thalassemia, Parkinson's disease, congenital blindness, amyloidosis, and cancer, to name a few.
This textbook is designed to be used in a modular fashion. No course would be expected to use all chapters in the book, nor necessarily in the same order in which they appear. The organization of the book gives wide latitude to course coordinators to make their own choices of which virus groups will be covered. Chapters are designed to accompany a 50-minute lecture on the subject, or, in some cases, two or three such lectures. It should be possible to read each chapter in 30-60 minutes, including examination of figures and tables. Lecturers might want to supplement material given in the text with experimental methods or results, which are not covered because of lack of space.
The book is organized into 11 sections and 42 chapters. Four introductory chapters in Section I cover the history of virology and the virus life cycle, virus structure, virus classification, and the entry of viruses into animal cells. Five chapters in Section II cover well-studied bacteriophages. These are included because bacteriophages are among the best-known viruses, and because much of our knowledge of molecular biology and virology began with their study. Furthermore, bacteriophages are the source of many tools commonly used in modern molecular and cell biology laboratories. A final chapter in Section II covers exciting new knowledge about the sometimes-bizarre viruses that infect archaea, members of the third domain of life, alongside bacteria and eukaryotes.
Sections III through VII cover viruses of eukaryotes, with an emphasis on viruses that infect humans and other vertebrates. The division into sections is based on the nature of the viral genome and viral replication strategies: positive-strand RNA viruses (Section III), negative-strand and double-stranded RNA viruses (Section IV), DNA viruses (Sections V and VI), and viruses that use reverse transcriptase (Section VII). Within a section, smaller and simpler viruses are discussed first, followed by larger and more complex viruses. In this way, concepts that are learned about simpler viruses can be applied when more complex viruses are encountered.
Section VIII covers small infectious entities that are not viruses: viroids, which are virus-like nucleic acids that replicate but code for no proteins; and prions, which are infectious proteins that contain no detectable nucleic acid. Section IX includes chapters on viruses that infect algae, invertebrates, and plants. The "giant" viruses are discussed in the chapter on viruses of algae. Section X covers host defenses against virus infection, and Section XI has been expanded to include not only chapters on vaccines and antiviral chemotherapy but also two new chapters on oncolytic viruses and viral gene therapy.
Each chapter begins with an outline. For chapters that cover virus families, these outlines are "thumbnail sketches" that contain some basic information about virion structure, genome organization, replication strategies, diseases caused, and distinctive characteristics shared by viruses in that family. These outlines are designed to serve as study aids that will help students understand and remember common features of the viruses they study.
Subheadings within each chapter are explanatory phrases, telling the reader what will be discussed in the next several paragraphs. These subheadings (collected in the Table of Contents) can also be read...
Dateiformat: ePUBKopierschutz: Adobe-DRM (Digital Rights Management)
Systemvoraussetzungen:
Das Dateiformat ePUB ist sehr gut für Romane und Sachbücher geeignet – also für „fließenden” Text ohne komplexes Layout. Bei E-Readern oder Smartphones passt sich der Zeilen- und Seitenumbruch automatisch den kleinen Displays an. Mit Adobe-DRM wird hier ein „harter” Kopierschutz verwendet. Wenn die notwendigen Voraussetzungen nicht vorliegen, können Sie das E-Book leider nicht öffnen. Daher müssen Sie bereits vor dem Download Ihre Lese-Hardware vorbereiten.Bitte beachten Sie: Wir empfehlen Ihnen unbedingt nach Installation der Lese-Software diese mit Ihrer persönlichen Adobe-ID zu autorisieren!
Weitere Informationen finden Sie in unserer E-Book Hilfe.